Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate for induction of general anesthesia
ChiCTR2000031798Phase 4Recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Success rate of anesthesia induction. Started Apr 2020; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000031798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031798.